Symbol="CPRX"
AssetType="Common Stock"
Name="Catalyst Pharmaceuticals Inc"
Description="Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, neuromuscular, and chronic neurological diseases in the United States. The company is headquartered in Coral Gables, Florida."
CIK="1369568"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="355 ALHAMBRA CIRCLE, SUITE 1250, CORAL GABLES, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1539773000"
EBITDA="127886000"
PERatio="16.28"
PEGRatio="0"
BookValue="3.15"
DividendPerShare="0"
DividendYield="0"
EPS="0.88"
RevenuePerShareTTM="2.465"
ProfitMargin="0.388"
OperatingMarginTTM="0.468"
ReturnOnAssetsTTM="0.229"
ReturnOnEquityTTM="0.359"
RevenueTTM="256480000"
GrossProfitTTM="160021000"
DilutedEPSTTM="0.88"
QuarterlyEarningsGrowthYOY="1.167"
QuarterlyRevenueGrowthYOY="0.981"
AnalystTargetPrice="22.4"
TrailingPE="16.28"
ForwardPE="19.3"
PriceToSalesRatioTTM="9.14"
PriceToBookRatio="6.47"
EVToRevenue="7.8"
EVToEBITDA="17.72"
Beta="1.129"
num_52WeekHigh="22.11"
num_52WeekLow="11.09"
num_50DayMovingAverage="12.84"
num_200DayMovingAverage="15.33"
SharesOutstanding="106507000"
DividendDate="None"
ExDividendDate="None"
symbol="CPRX"
open="14.27"
high="14.30"
low="13.98"
price="14.12"
volume="1400511.00"
latest_trading_day="2023-08-09"
previous_close="14.33"
change="-0.21"
change_percent="-1.4655%"
aroon_positive_momentum_days="17"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="17"
Volume_recent_avg="1814076"
Change_recent_avg="-0.03"
Delta_recent_avg="0.53"
Variance_recent_avg="0.26"
Change_ratio_recent_avg="-0.24"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="17"
Aroon_momentum_negative="83"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="625"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_positive_thumbnail_id_2="707"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0001.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
